Nicolas Rousseau
Seminars
Thursday 25th September 2025
Panel Discussion: Accelerating Scalable & Cost-Effective Extra-Cellular Vesicle Manufacturing for the Development of Therapeutics for Regenerative, Precision & CGT Therapies
12:00 pm
- Exploring cost-efficient exosome sources such as bodily fluids to reduce the high production costs associated with cellderived exosomes
- Understanding the complexities involved in setting up pipelines for the purification and production of engineered exosomes to optimize cost considerations throughout the development process
- Delving into the factors contributing to the cost of engineered exosomes, including production methods and regulatory compliance, for strategic planning to manage expenses effectively
Thursday 25th September 2025
EVerGel for Crohn Perianal Fistula: Exosomes Embedded in Hydrogel
8:30 am
- Showcasing preclinical data in perianal fistula
- Highlighting quality control and regulatory challenges of a formulation with a hydrogel
- Outlining the regulatory preparation of a phase 1b/2a clinical trial in Crohn fistula
NEW DATA!
Wednesday 24th September 2025
Biopharma Leaders Panel Discussion: Unlocking the Next Wave of Safe & Efficient Exosome-Based Therapeutics Towards Clinical & Commercial Reality
2:10 pm
This is your chance to hear from pioneering executive leaders from the exosome and extra-cellular vesicle community who will discuss their strategies, challenges, and future perspectives for exosome technology and clinically relevant therapeutic applications.
- What are the future opportunities, promising targets, and applications on the horizon for exosomes to achieve clinical success?
- What can we learn from past experiences, principles, and guidelines to roadmap and accelerate the next 5 years of therapeutic development?
- What advice can you give this room of exosome experts to reduce risk, extend cash flow, and become an investable SME?
Moderator: Michael Binks, Chief Medical Officer of Capricor Therapeutics
